One common question patients ask me is how Cartiheal compares to osteochondral allograft transplantation (OCA) and matrix-associated autologous chondrocyte implantation (MACI). Here’s a high level answer:
Cartiheal is approved in patients with degenerative cartilage lesions; I think it is a good option in those with bone edema or a bone/cartilage lesion, especially in those over 35. Matrix-associated autologous chondrocyte implantation (MACI) is indicated for repair of single or multiple cartilage defects and requires two operations.
Osteochondral allograft transplantation (OCA) is for a single focal lesion that is greater than two square cm. It heals more quickly than MACI and requires donor tissue. There is a lot of overlap in their indications.
Have other questions? Please reach out to my office or check out my most commonly asked questions and answers.